Quality Of Life Improvement In High And Very High Cardiovascular Risk Patients Treated With Pcsk9 Inhibitors

Autor: Cesaro, A., Gragnano, F., Fimiani, F., Moscarella, E., Pariggiano, I., Diana, V., Carfora, V., Conte, M., Falato, S., Cesarano, M., Di Maio, D., Calabrò, P.
Zdroj: In Atherosclerosis August 2019 287:e199-e199
Databáze: ScienceDirect